fda bpc-157 warning unapproved drug letter new BPC-157: Miracle Healing Peptide or Hidden Danger? FDA's Overreach on Compounded Peptides

WADA and militarydrugpolicy platforms treat BPC157 as a prohibited or unapproved substance, meaning athletes and service members can face sanctions

Principal Display Panel - Medication Box Rx only MEDICATION BOX (Box 1 of 2) NDC 62064-381-04 4 vials EGRIFTA WRTM (tesamorelin) for injection 11.6 mg/vial For Subcutaneous Use Single-patient-use vial Sterile lyophilized powder New Formulation, Dose, Mixing Instructions, and Storage One (1) mixed EGRIFTA WR vial provides daily doses for seven (7) days EGRIFTA WR and EGRIFTA SV are not substitutable

AOD 9604 is not FDA-approved and is sold as a research compound

I feel like Im improving, Im happy with the results Good products I think the medicine is working well

This helps ensure that the treatments are not causing harm and that they are providing the intended benefits